Data Insights
By Company Name
No filters selected
By Disease Name
No filters selected
By Drug Name
No filters selected
By Themes
No filters selected
Showing 2 results out of 2
Data Insights
Fresolimumab by Sanofi for Non-Small Cell Lung Cancer: Likelihood of Approval
Fresolimumab is under clinical development by Sanofi and currently in Phase II for Non-Small Cell Lung Cancer. According to GlobalData,...
Data Insights
Fresolimumab by Sanofi for Non-Small Cell Lung Cancer: Likelihood of Approval
Fresolimumab is under clinical development by Sanofi and currently in Phase II for Non-Small Cell Lung Cancer. According to GlobalData,...